课题基金 / 基金详情

QUALITY OF LIFE IN HEAD AND NECK CANCER

QUALITY OF LIFE IN HEAD AND NECK CANCER
头颈癌的生活质量
批准号:
2882523
负责人:
Avraham Eisbruch
金额:
$7.43万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-03-01 至 2000-02-29

项目摘要

项目成果

Avraham Eisbruch的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Applicant's Description) Standard radiation for advanced head and neck malignancies typically causes permanent xerostomia that is cited by patients as a major cause of reduced quality of life. In an effort to reduce radiation-induced xerostomia, we have initiated a study of the feasibility of sparing major salivary gland tissue while adequately irradiating the targets in patients requiring comprehensive, bilateral neck irradiation. For this purpose, we utilize computed-tomography based conformal, 3-dimensional (3D) radiation planning and treatment tools. We have achieved adequate target coverage and significant sparing of parotid gland tissue. Significant saliva flow preservation has been achieved. The goal of this work is to improve long-term quality of life following radiation. Our aims in the proposed study are to assess the extent of improvement in the quality of life in patients treated using these techniques compared with s i milar patients treated with standard techniques, to assess whether improvements in xerostomia and quality of life are related to the amount of saliva flow retained following radiation, and to determine the relationships between the volumes irradiated and the doses delivered to the parotid glands and their function following radiation. The results will establish the methodology for conducting randomized, larger trials that are required to test the extent to which the techniques we have utilized improve quality of life while preserving tumor control rates compared with standard techniques, and to determine if such trials are worth undertaking.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
INDIVIDUALIZING IMRT TREATMENT IN BRAIN AND HEAD/NECK CA
CONCURRENT RADIATION AND GEMCITABINE FOR UNRESECTABLE HEAD AND NECK TUMORS
QUALITY OF LIFE IN HEAD AND NECK CANCER
CONCURRENT RADIATION AND GEMCITABINE FOR UNRESECTABLE HEAD AND NECK TUMORS
海外基金